Zhejiang Hisun Biomaterials Co.Ltd. (SHA:688203)
13.01
-0.16 (-1.21%)
Mar 13, 2026, 4:00 PM EDT
SHA:688203 Revenue
In the year 2025, Zhejiang Hisun Biomaterials Co.Ltd. had annual revenue of 851.59M CNY with 0.76% growth. Zhejiang Hisun Biomaterials Co.Ltd. had revenue of 230.17M in the quarter ending December 31, 2025, with 23.80% growth.
Revenue
851.59M
Revenue Growth
+0.76%
P/S Ratio
3.07
Revenue / Employee
1.91M
Employees
446
Market Cap
2.62B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 851.59M | 6.40M | 0.76% |
| Dec 31, 2024 | 845.19M | 91.87M | 12.20% |
| Dec 31, 2023 | 753.32M | 147.88M | 24.43% |
| Dec 31, 2022 | 605.43M | 20.43M | 3.49% |
| Dec 31, 2021 | 585.01M | 322.34M | 122.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Maoming Petro-Chemical Shihua | 3.21B |
| Guangdong Tianan New Material | 3.18B |
| Daqing Huake Company | 1.90B |
| Jointown Aesthetics Valley | 1.02B |
| Zhe Jiang Dayang Biotech Group | 985.47M |
| Yangfan New Materials (Zhejiang) | 912.69M |
| Yangzhou Chenhua New Material | 878.67M |
| Zhejiang Benli Technology | 651.33M |